Amikacin liposomal - SkyePharma

Drug Profile

Amikacin liposomal - SkyePharma

Alternative Names: DepoAmikacin™

Latest Information Update: 29 May 2002

Price : $50

At a glance

  • Originator SkyePharma Inc
  • Class Aminoglycosides; Antibacterials; Small molecules
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Postoperative infections

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 29 May 2002 Discontinued - Phase-I for Postoperative infections in USA (Parenteral)
  • 14 Feb 2000 DepoTech is now called SkyePharma Inc
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top